CagriSema demonstrates meaningfully greater weight loss than semaglutide alone (20.4% vs 14.9%), driven by the complementary amylin pathway from cagrilintide
Sometimes molecules decompose to produce high energy, unstable fragments that can react with other molecules around them
It is also used to treat pernicious anemia, vitamin B 12 deficiency (due to low intake from food or inability to absorb due to genetic or other factors), thyrotoxicosis, hemorrhage, malignancy, liver disease and kidney disease
BPC-157 is an unlicensed synthetic peptide not approved by the MHRA, EMA, or FDA for human use
Aging cell 2021;20, e13486, doi:10.1111/acel.13486
The lab-made kind are often used in medications, supplements, and injectable products